Literature DB >> 22040193

Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders.

Benjamin I Goldstein1, Katelyn A Collinger, Francis Lotrich, Anna L Marsland, Mary-Kay Gill, David A Axelson, Boris Birmaher.   

Abstract

Mood symptoms in adult bipolar disorder are associated with increased proinflammatory markers and decreased brain-derived neurotrophic factor (BDNF). We examined serum interleukin-6, high-sensitivity C-reactive protein (hsCRP), and BDNF among 30 bipolar disorder adolescents. Hypomanic/manic symptoms were positively associated with hsCRP. BDNF levels were negatively associated with interleukin-6. Forty percent had cardiovascular high-risk hsCRP levels. Larger longitudinal studies are warranted.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22040193      PMCID： PMC3205790          DOI： 10.1089/cap.2011.0009

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


  62 in total

1.  The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations.

Authors:  U E Lang; R Hellweg; T Sander; J Gallinat
Journal:  Mol Psychiatry       Date:  2009-02       Impact factor: 15.992

2.  Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.

Authors:  Koji Matsuo; Consuelo Walss-Bass; Fabiano G Nery; Mark A Nicoletti; John P Hatch; Benicio N Frey; Emel S Monkul; Giovana B Zunta-Soares; Charles L Bowden; Michael A Escamilla; Jair C Soares
Journal:  Neuropsychopharmacology       Date:  2009-03-18       Impact factor: 7.853

3.  Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study.

Authors:  Boris Birmaher; David Axelson; Benjamin Goldstein; Michael Strober; Mary Kay Gill; Jeffrey Hunt; Patricia Houck; Wonho Ha; Satish Iyengar; Eunice Kim; Shirley Yen; Heather Hower; Christianne Esposito-Smythers; Tina Goldstein; Neal Ryan; Martin Keller
Journal:  Am J Psychiatry       Date:  2009-05-15       Impact factor: 18.112

4.  Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.

Authors:  Yasemin Gorgulu; Okan Caliyurt
Journal:  Brain Res Bull       Date:  2009-07-01       Impact factor: 4.077

5.  The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.

Authors:  S Yasuda; M-H Liang; Z Marinova; A Yahyavi; D-M Chuang
Journal:  Mol Psychiatry       Date:  2007-10-09       Impact factor: 15.992

6.  Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States.

Authors:  Benjamin I Goldstein; Andrea Fagiolini; Patricia Houck; David J Kupfer
Journal:  Bipolar Disord       Date:  2009-09       Impact factor: 6.744

7.  Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.

Authors:  Marcia Kauer-Sant'Anna; Flávio Kapczinski; Ana C Andreazza; David J Bond; Raymond W Lam; L Trevor Young; Lakshmi N Yatham
Journal:  Int J Neuropsychopharmacol       Date:  2008-09-04       Impact factor: 5.176

Review 8.  Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

Authors:  Andrew H Miller; Vladimir Maletic; Charles L Raison
Journal:  Biol Psychiatry       Date:  2009-01-15       Impact factor: 13.382

9.  Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.

Authors:  Elisa Brietzke; Laura Stertz; Brisa Simões Fernandes; Marcia Kauer-Sant'anna; Marcello Mascarenhas; Andréia Escosteguy Vargas; José Artur Chies; Flávio Kapczinski
Journal:  J Affect Disord       Date:  2009-02-28       Impact factor: 4.839

10.  Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.

Authors:  Neil A Harrison; Lena Brydon; Cicely Walker; Marcus A Gray; Andrew Steptoe; Hugo D Critchley
Journal:  Biol Psychiatry       Date:  2009-05-07       Impact factor: 13.382
View more
  31 in total

Review 1.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

Review 2.  Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.

Authors:  George Anderson; Michael Maes
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

Review 3.  Inflammatory mediators of cognitive impairment in bipolar disorder.

Authors:  Isabelle E Bauer; Michaela C Pascoe; Bianca Wollenhaupt-Aguiar; Flavio Kapczinski; Jair C Soares
Journal:  J Psychiatr Res       Date:  2014-05-02       Impact factor: 4.791

Review 4.  Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy.

Authors:  Shakuntla Gondalia; Lisa Parkinson; Con Stough; Andrew Scholey
Journal:  Psychopharmacology (Berl)       Date:  2019-04-30       Impact factor: 4.530

Review 5.  Is it time for immunopsychiatry in psychotic disorders?

Authors:  Marion Leboyer; José Oliveira; Ryad Tamouza; Laurent Groc
Journal:  Psychopharmacology (Berl)       Date:  2016-03-18       Impact factor: 4.530

6.  Il1-β involvement in cognitive impairment after sepsis.

Authors:  Francielle Mina; Clarissa M Comim; Diogo Dominguini; Omar J Cassol; Dhébora M Dall Igna; Gabriela K Ferreira; Milena C Silva; Leticia S Galant; Emílio L Streck; João Quevedo; Felipe Dal-Pizzol
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

7.  Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder.

Authors:  Gustavo Scola; Robert K McNamara; Paul E Croarkin; Jarrod M Leffler; Kathryn R Cullen; Jennifer R Geske; Joanna M Biernacka; Mark A Frye; Melissa P DelBello; Ana C Andreazza
Journal:  J Affect Disord       Date:  2015-12-23       Impact factor: 4.839

8.  Inflammatory markers among adolescents and young adults with bipolar spectrum disorders.

Authors:  Benjamin I Goldstein; Francis Lotrich; David A Axelson; Mary Kay Gill; Heather Hower; Tina R Goldstein; Jieyu Fan; Shirley Yen; Rasim Diler; Daniel Dickstein; Michael A Strober; Satish Iyengar; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Clin Psychiatry       Date:  2015-11       Impact factor: 4.384

9.  Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders.

Authors:  David J Miklowitz; Larissa C Portnoff; Casey C Armstrong; Danielle Keenan-Miller; Elizabeth C Breen; Keely A Muscatell; Naomi I Eisenberger; Michael R Irwin
Journal:  Psychiatry Res       Date:  2016-05-07       Impact factor: 3.222

10.  Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.

Authors:  Francis E Lotrich; Salwa Albusaysi; Robert E Ferrell
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.